I 

117TH CONGRESS 

1ST SESSION H. R. 330 

To direct the Federal Emergency Management Agency to assist States and 

local governments with the distribution and tracking of vaccines for 

COVID–19, to direct the Secretary of Health and Human Services to 

carry out a national program to oversee the collection and maintenance 

of all Federal and State data on vaccinations of individuals in the 

United States for COVID–19 to achieve mass vaccination saturation 

immunity, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

JANUARY 15, 2021 

Ms. JACKSON LEE (for herself, Mr. PAYNE, Mr. BROWN, and Mr. JONES) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Transportation 

and Infrastructure, for a period to be subsequently determined by the 

Speaker, in each case for consideration of such provisions as fall within 

the jurisdiction of the committee concerned 

A BILL 

To direct the Federal Emergency Management Agency to 

assist States and local governments with the distribution 

and tracking of vaccines for COVID–19, to direct the 

Secretary of Health and Human Services to carry out 

a national program to oversee the collection and maintenance of all Federal and State data on vaccinations 

of individuals in the United States for COVID–19 to 

achieve mass vaccination saturation immunity, and for 

other purposes. 


kjohnson on DSK79L0C42PROD with BILLS
2 

•HR 330 IH

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Delivering COVID5 19 Vaccinations to All Regions and Vulnerable Commu6 nities Act of 2021’’ or the ‘‘COVID-19 Delivery Act’’. 

7 SEC. 2. FEMA ASSISTANCE FOR COVID–19 VACCINATIONS. 

8 At the request of a State or local government, the 

9 Administrator of the Federal Emergency Management 

10 Agency shall— 

11 (1) coordinate efforts for vaccine delivery, in12 cluding from manufacturing sites to inoculation 

13 sites; 

14 (2) monitor shipments of vaccines through a 

15 24-hour tracking system, including readings on the 

16 temperature, real-time location, origin, destination 

17 data, anticipated time of arrival, and report to re18 cipients on changes and updates on the progress of 

19 their delivery shipments and any changes that may 

20 impact expected delivery or the viability of the vac21 cine while in transit; 

22 (3) develop an advanced communication system 

23 to allow the Department of Health and Human 

24 Services and public health departments to commu25 nicate and share information about vaccine readiVerDate Sep 11 2014 22:06 Feb 06, 2021 Jkt 019200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\H330.IH H330

kjohnson on DSK79L0C42PROD with BILLS
3 

•HR 330 IH

1 ness, capability of receiving vaccines, delivery loca2 tions, details of facility capability of storing and se3 curing vaccines, personnel authorized to receive de4 liveries, logistics for delivering vaccines to patients, 

5 report on vaccine receipts, condition of vaccines, pa6 tient reactions, and feedback on how to improve the 

7 process; 

8 (4) secure transportation for delivery or use of 

9 vaccines, and if requested, security for the vaccine 

10 delivery sites or inoculation locations to ensure the 

11 life and safety of personnel and patients who seek to 

12 provide or receive vaccinations free of interference or 

13 threat; 

14 (5) design custom software applications (Apps) 

15 with the Department of Health and Human Services 

16 for use by public health agencies and any company 

17 or person administering vaccines to provide informa18 tion to patients on the vaccine being received, the 

19 date of a second dose and the location of the dose 

20 if required, including generating a token that cor21 responds to an individual’s vaccination record to en22 sure that the right vaccine is administered and if a 

23 second inoculation is required and to ensure that an 

24 individual is not vaccinated with different vaccines, 


kjohnson on DSK79L0C42PROD with BILLS
4 

•HR 330 IH

1 and any additional information that may be perti2 nent in the future; 

3 (6) develop a public education and patient en4 gagement program about the safety and availability 

5 of vaccines that also ensures that individuals in 

6 areas and locations where vulnerable populations 

7 often do not have easy access to health care or vac8 cinations are informed about vaccine availability; 

9 and 

10 (7) acting through the Department of Health 

11 and Human Services, provide additional vaccination 

12 centers, in addition to State and local government 

13 sites, to augment vaccinations occurring within such 

14 States and local governments to address access to 

15 at-risk communities when vaccination rates are 

16 below 80 percent for a population residing with in 

17 a census block or track that is experiencing a great18 er incidence of serious complications, such as hos19 pitalizations and deaths that are above the propor20 tional representation of the at-risk group when com21 pared to the general population, establishing the 

22 need for a targeted vaccination effort to reduce the 

23 incidence of infections for those individuals at great24 est risk for hospitalizations and death from COVID25 19. 


kjohnson on DSK79L0C42PROD with BILLS
5 

•HR 330 IH

1 SEC. 3. CDC REQUIREMENTS. 

2 The Centers for Disease Control and Prevention shall 

3 track the dissemination of inoculations and report on effi4 ciencies, effectiveness, or deficiencies of local and State 

5 COVID-19 vaccination programs, including the avail6 ability of certified individuals under Federal, State, or ter7 ritorial authority to administer a vaccination under State 

8 law, and report to Congressional oversight committees in 

9 the House of Representatives and the Senate on findings 

10 and recommendations. 

11 SEC. 4. HHS MANAGEMENT OF COVID–19 VACCINATION 

12 DATA TO ACHIEVE MASS VACCINATION SATU13 RATION IMMUNITY. 

14 (a) IN GENERAL.—The Secretary of Health and 

15 Human Services (in this section referred to as the ‘‘Sec16 retary’’) shall carry out a national program to oversee the 

17 collection and maintenance of all Federal and State data 

18 on vaccinations of individuals in the United States for 

19 COVID–19, including tracking booster vaccinations, to 

20 achieve mass vaccination saturation immunity. 

21 (b) APPLICABLE PRIVACY LAW; PENALTIES.— 

22 (1) IN GENERAL.—The Secretary shall main23 tain data on vaccinations for COVID–19 in accord24 ance with all applicable privacy and security law, in25 cluding HIPAA privacy and security law (as defined 


kjohnson on DSK79L0C42PROD with BILLS
6 

•HR 330 IH

1 in section 3009(a)(2) of the Public Health Service 

2 Act (42 U.S.C. 300jj–19(a)(2)). 

3 (2) PENALTIES.—Any person who discloses or 

4 uses data on vaccinations for COVID–19 in violation 

5 of any provision of law referred to in paragraph 

6 (1)— 

7 (A) shall be imprisoned for not more than 

8 5 years, or fined in accordance with title 18, or 

9 both; and 

10 (B) shall be subject, in addition to any 

11 other penalties that may be prescribed by law, 

12 to a civil money penalty of not more than 

13 $10,000 for each such violation. 

14 (c) DATA RETENTION LIMITATION.—The Secretary 

15 shall destroy any data maintained pursuant to subsection 

16 (a) by the end of the 5-year period beginning on the date 

17 of receipt or collection of the data, whichever is later. 

18 (d) TRANSMISSION OF STATE DATA.—The Secretary 

19 shall take such steps as may be necessary to encourage 

20 and assist each State in transmitting to the Secretary on 

21 an ongoing basis the State’s data with respect to vaccina22 tion of individuals in such State for COVID–19. 

23 (e) OMBUDSMAN.—The Secretary shall appoint an 

24 ombudsman to— 


kjohnson on DSK79L0C42PROD with BILLS
7 

•HR 330 IH

1 (1) support public and stakeholder input on the 

2 activities carried out pursuant to this section; 

3 (2) provide advocacy and advice for those who 

4 elect not to be vaccinated for COVID–19; and 

5 (3) champion the privacy and civil liberty rights 

6 of individuals in the United States in connection 

7 with vaccination for COVID–19. 

8 (f) COLLABORATION.—In carrying out this section, 

9 the Secretary shall collaborate with stakeholders in estab10 lishing vaccine inoculation centers in locations including— 

11 (1) stadiums, arenas, elementary and secondary 

12 schools, colleges and universities, and places of wor13 ship; and 

14 (2) other locations determined by the Secretary 

15 to be conducive to reaching the greatest number of 

16 people in need of inoculations for COVID–19. 

17 (g) ADVISORY BOARD.—For the purpose achieving 

18 mass vaccination saturation immunity to COVID–19 in 

19 the United States, the Secretary shall establish a stake20 holder advisory board to support the collaboration and co21 operation of entities including Federal, State, and local 

22 governments, businesses, colleges, universities, elementary 

23 and secondary schools, hospitals, clinics, professional med24 ical associations, and such other entities as the Secretary 

25 determines to be essential to such purpose. 


kjohnson on DSK79L0C42PROD with BILLS
8 

•HR 330 IH

1 (h) REPORTS.—On a daily or weekly basis, subject 

2 to subsection (b), the Secretary shall submit to the Con3 gress and make public reports on the activities carried out 

4 under this section, including such data as the Director of 

5 the Centers for Disease Control and Prevention deter6 mines to be relevant to analyzing inoculation statistics and 

7 progress toward achieving mass vaccination saturation im8 munity. 

Æ 


kjohnson on DSK79L0C42PROD with BILLS